高榕创投
@gaorong
创造美好生活
Huayi Quantum Secures Over 100 Million Yuan in Pre-A Round to Accelerate Development of Novel Ion-Trap Quantum Computer
Committed to achieving sustained, rapid growth in qubit scale.
Vertilite closes new funding round worth hundreds of millions of RMB, solidifying its position in the top tier of VCSEL laser chip makers globally
Beyond consumer electronics and automotive electronics, the company is now pushing further into the high-end optical communications chip sector.
AI Itinerary Planning, Trip Booking... How Vtrip Redefines AI-Native Travel Products | Gaorong Ventures --- When ChatGPT first launched in late 2022, it sparked immediate excitement across the travel industry. Travel is a classic information-asymmetry business — fragmented supply chains, complex decision-making, and high service costs. The industry had long dreamed of a "travel super assistant," and large language models finally seemed to make it possible. But two years later, the reality has been underwhelming. Most so-called "AI travel" products remain stuck at the chatbot level: they can answer questions and draft itineraries, but can't actually complete bookings. The gap between "generating a plan" and "executing a trip" remains vast. Vtrip (视旅科技), a startup founded in 2021, is taking a different approach. Rather than bolting AI onto existing travel infrastructure, it's rebuilding the entire travel product from the ground up with AI at its core. The company recently closed a new funding round led by Gaorong Ventures, with participation from existing investors. We spoke with Vtrip's founding team about what "AI-native travel" actually means in practice. ## From "AI-Assisted" to "AI-Native" The travel industry's first
Travel LLMs are putting this generation's young travelers in a league of their own.
How Far Are We from LLMs Creating New Commercial Growth and Super Apps? | Ronghui · Inside Volcano Engine
Large language models are driving new business growth and novel forms of interaction.
Onto Innovation Completes Over $50 Million Series A Financing to Accelerate Deep Pipeline Expansion in Nucleic Acid Drugs
Focused on drug development based on antisense oligonucleotide technology.
Genmab Acquires ProfoundBio for $1.8 Billion | Gaorong Ventures News
Accelerate the development and unlock the full potential of ADC therapies.
Inside BYD: How "Yangwang" Is Redefining Disruptive Tech, and Decoding the "Xuanji" Intelligence System | Ronghui
Unwavering investment in disruptive new technologies.
High-end networking chip company **Zhuanxin** has completed its Series A2 funding round, targeting the AI computing network market.
Meeting the high-bandwidth networking demands of AI computing clusters.
Rongbao | Hydrogen energy and battery management tech firms secure new funding; innovative drug targets precise efficacy
Grow, toward the future.
ProfoundBio Closes $112 Million Series B to Advance ADC Drug Candidates Into Pivotal Clinical Development
Delivering breakthrough therapies for cancer patients.
Congratulations to Alto Neuroscience on its NYSE Listing, Advancing Precision Medicines in Mental Health | Gaorong Ventures News
Providing personalized and efficient treatment for patients with mental illness.
Chint Group's Taihydrogen Closes 150 Million Yuan Pre-A Round to Expand "Green Power + Green Hydrogen" Applications
Advance the development and application of hydrogen energy technology.